As of Feb 12
| +0.08 / +1.77%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 14.00. The median estimate represents a +225.38% increase from the last price of 4.61.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.